Strains of coxsackie virus B4 differed in their ability to induce acute pancreatitis and the responses were negatively correlated to glucose tolerance

[1]  N. Chapman,et al.  An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses , 2005, Archives of Virology.

[2]  A. Notkins.  Virus-induced diabetes mellitus , 2005, Archives of Virology.

[3]  G. Friman,et al.  Coxsackie B virus IgM in children at onset of Type 1 (insulin-dependent) diabetes mellitus: evidence for IgM induction by a recent or current infection , 1992, Diabetologia.

[4]  O. Ganda,et al.  Pre-Type 1 (insulin-dependent) diabetes: common endocrinological course despite immunological and immunogenetic heterogeneity , 1984, Diabetologia.

[5]  M. Craig,et al.  Reduced frequency of HLA DRB1*03-DQB1*02 in children with type 1 diabetes associated with enterovirus RNA. , 2003, The Journal of infectious diseases.

[6]  H. Fechner,et al.  Highly variable expression of virus receptors in the human cardiovascular system , 2002, Zeitschrift für Kardiologie.

[7]  J. Westman,et al.  Complete nucleotide sequence of a Coxsackievirus B‐4 strain capable of establishing persistent infection in human pancreatic islet cells: Effects on insulin release, proinsulin synthesis, and cell morphology , 2002, Journal of medical virology.

[8]  K. Klingel,et al.  Comparative analysis of two coxsackievirus B3 strains: Putative influence of virus‐receptor interactions on pathogenesis , 2002, Journal of medical virology.

[9]  T. Tuvemo,et al.  Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of type 1 diabetic children at onset. , 2002, Diabetes.

[10]  J. Galama,et al.  Functional impairment and killing of human beta cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains , 2002, Diabetologia.

[11]  N. Sarvetnick,et al.  Presented antigen from damaged pancreatic beta cells activates autoreactive T cells in virus-mediated autoimmune diabetes. , 2002, The Journal of clinical investigation.

[12]  G. Frisk,et al.  The replication of certain Coxsackie B virus strains in CHO cells. , 2001, Journal of virological methods.

[13]  M. Atkinson,et al.  Type 1 diabetes: new perspectives on disease pathogenesis and treatment , 2001, The Lancet.

[14]  G. Frisk.  Mechanisms of chronic enteroviral persistence in tissue , 2001, Current opinion in infectious diseases.

[15]  N. Sarvetnick,et al.  Requirements for viral-mediated autoimmune diabetes: beta-cell damage and immune infiltration. , 2001, Journal of autoimmunity.

[16]  M. Ericsson,et al.  Differences in inhibition of replication between Coxsackie B4 virus strains in various cell lines by antibodies to some cell surface proteins. , 2001, Virus research.

[17]  M. Netea,et al.  Enterovirus-induced production of pro-inflammatory and T-helper cytokines by human leukocytes. , 2000, Cytokine.

[18]  J. Galama,et al.  Acute onset of type I diabetes mellitus after severe echovirus 9 infection: putative pathogenic pathways. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  J. Whitton,et al.  Coxsackievirus infection of the pancreas: evaluation of receptor expression, pathogenesis, and immunopathology. , 2000, Virology.

[20]  K. Kain,et al.  The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus. , 2000, Virology.

[21]  N. Chapman,et al.  Genomic Determinants of Cardiovirulence in Coxsackievirus B3 Clinical Isolates: Localization to the 5′ Nontranslated Region , 2000, Journal of virology.

[22]  G. Frisk,et al.  Tissue Culture of Isolated Human Pancreatic Islets Infected With Different Strains of Coxsackievirus B4: Assessment of Virus Replication and Effects on Islet Morphology and Insulin Release , 2000, International journal of experimental diabetes research.

[23]  L. Bouwens,et al.  Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells. , 2000, The Journal of clinical endocrinology and metabolism.

[24]  P. E. Tam,et al.  Molecular Mechanisms of Coxsackievirus Persistence in Chronic Inflammatory Myopathy: Viral RNA Persists through Formation of a Double-Stranded Complex without Associated Genomic Mutations or Evolution , 1999, Journal of Virology.

[25]  G. Duncan,et al.  Two determinants in the capsid of a persistent type 3 poliovirus exert different effects on mutant virus uncoating. , 1999, The Journal of general virology.

[26]  C. Mathieu,et al.  The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic beta-cells. , 1999, European cytokine network.

[27]  G. Clements,et al.  Enterovirus variants in the serum of children at the onset of Type 1 diabetes mellitus , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[28]  B. Lina,et al.  Postpolio syndrome: poliovirus persistence is involved in the pathogenesis , 1999, Journal of Neurology.

[29]  Troy Krahl,et al.  Diabetes induced by Coxsackie virus: Initiation by bystander damage and not molecular mimicry , 1998, Nature Medicine.

[30]  T. Hovi.  Molecular epidemiology of enteroviruses with special reference to their potential role in the etiology of insulin-dependent diabetes mellitus (IDDM). A review. , 1998, Clinical and diagnostic virology.

[31]  N. Chapman,et al.  Coxsackieviruses and diabetes , 1997, BioEssays : news and reviews in molecular, cellular and developmental biology.

[32]  D. Hober,et al.  Detection of Coxsackie B Virus RNA sequences in whole blood samples from adult patients at the onset of type I diabetes mellitus , 1997, Journal of medical virology.

[33]  G. Frisk,et al.  Antibody responses to different strains of coxsackie B4 virus in patients with newly diagnosed type I diabetes mellitus or aseptic meningitis. , 1997, The Journal of infection.

[34]  J. Bergelson,et al.  Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors. , 1997, The Journal of infectious diseases.

[35]  J. Bergelson,et al.  Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5 , 1997, Science.

[36]  N. Chapman,et al.  Genetics of coxsackievirus virulence. , 1997, Current topics in microbiology and immunology.

[37]  A. Ulfgren,et al.  Cytokine Production in Hearts of Trypanosoma cruzi‐Infected CBA Mice: Do Cytokine Patterns in Chronic Stage Reflect the Establishment of Myocardial Pathology? , 1996, Scandinavian journal of immunology.

[38]  H. Chase,et al.  Prediction of Type I Diabetes in First-Degree Relatives Using a Combination of Insulin, GAD, and ICA512bdc/IA-2 Autoantibodies , 1996, Diabetes.

[39]  M. Knip,et al.  Antibody cross‐reactivity induced by the homologous regions in glutamic acid decarboxylase (GAD65) and 2C protein of coxsackievirus B4 , 1996, Clinical and experimental immunology.

[40]  R. Bates,et al.  Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment , 1995, Journal of virology.

[41]  J. Tilles,et al.  Pathogenesis of virus-induced diabetes in mice. , 1995, The Journal of infectious diseases.

[42]  J. Bergelson,et al.  Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55) , 1995, Journal of virology.

[43]  R. Kandolf.  Molecular biology of viral heart disease. , 1993, Herz.

[44]  K. Klingel,et al.  Molecular mechanisms in the pathogenesis of enteroviral heart disease: acute and persistent infections. , 1993, Clinical immunology and immunopathology.

[45]  A. Ramsingh,et al.  Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype , 1993, Journal of virology.

[46]  G. Friman,et al.  The possible role of Coxsackie A and echo viruses in the pathogenesis of type I diabetes mellitus studied by IgM analysis. , 1992, The Journal of infection.

[47]  C. Christodoulou,et al.  Persistent poliovirus infection of human neuroblastoma cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[48]  T. Hyypiä,et al.  Coxsackievirus B3-induced acute pancreatitis: analysis of histopathological and viral parameters in a mouse model. , 1989, British journal of experimental pathology.

[49]  I. Gerling,et al.  Effect of Coxsackievirus B4 Infection in Mice on Expression of 64,000-Mr Autoantigen and Glucose Sensitivity of Islets Before Development of Hyperglycemia , 1988, Diabetes.

[50]  N. Chatterjee,et al.  Purification and characterization of a strain of coxsackievirus b4 of human origin that induces diabetes in mice , 1988, Journal of medical virology.

[51]  G. Friman,et al.  High frequency of coxsackie‐B‐virus‐specific IgM in children developing type I diabetes during a period of high diabetes morbidity , 1985, Journal of medical virology.

[52]  R. Gleason,et al.  Pre-Type I Diabetes: Linear Loss of Beta Cell Response to Intravenous Glucose , 1984, Diabetes.

[53]  A. Voller,et al.  ROLE OF COXSACKIE B VIRUSES IN INSULIN-DEPENDENT DIABETES MELLITUS , 1983, The Lancet.

[54]  T. Onodera,et al.  Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. , 1979, The New England journal of medicine.

[55]  T. Onodera,et al.  Virus-induced diabetes mellitus. XV. Beta cell damage and insulin- dependent hyperglycemia in mice infected with coxsackie virus B4 , 1978, The Journal of experimental medicine.